首页> 外文OA文献 >Are side effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
【2h】

Are side effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?

机译:是由四氢尼酚(THC)污染引起的大麻(CBD)产品的副作用吗?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cannabidiol (CBD)-containing products are widely marketed as over the counter products, mostly as food supplements, to avoid the strict rules of medicinal products. Side-effects reported in anecdotal consumer reports or during clinical studies were first assumed to be due to hydrolytic conversion of CBD to psychotropic Δ9-tetrahydrocannabinol (THC) in the stomach after oral consumption. However, research of pure CBD solutions stored in simulated gastric juice or subjected to various storage conditions such as heat and light with specific liquid chromatographic/tandem mass spectrometric (LC/MS/MS) and ultra-high pressure liquid chromatographic/quadrupole time-of-flight mass spectrometric (UPLC-QTOF) analyses was unable to confirm THC formation. Another hypothesis for the side-effects of CBD products may be residual THC concentrations in the products as contamination, because most of them are based on crude hemp extracts containing the full spectrum of cannabinoids besides CBD. Analyses of 67 food products of the German market (mostly CBD oils) confirmed this hypothesis: 17 products (25%) contained THC above the lowest observed adverse effects level (2.5 mg/day). Inversely, CBD was present in the products below the no observed adverse effect level. Hence, it may be assumed that the adverse effects of some commercial CBD products are based on a low-dose effect of THC and not due to effects of CBD itself. The safety, efficacy and purity of commercial CBD products is highly questionable, and all of the products in our sample collection showed various non-conformities to European food law such as unsafe THC levels, full-spectrum hemp extracts as non-approved novel food ingredients, non-approved health claims, and deficits in mandatory food labelling requirements. In view of the growing market for such lifestyle products, the effectiveness of the instrument of food business operators' own responsibility for product safety must obviously be challenged.
机译:大麻(CBD) - 悬挂产品广泛销售,大多是作为食品补充剂,以避免严格的药品规则。首先假设在胰岛素消费者报告中或在临床研究中报告的副作用是由于口服消耗后胃中CBD的水解转化为精神Δ9-四氢尼酚(THC)。然而,储存在模拟胃液中的纯CBD溶液或经受各种储存条件,例如具有特定液体色谱/串联质谱(LC / MS / MS)和超高压液相色谱/四极其时的热和光的各种储存条件-Flight质谱(UPLC-QTOF)分析无法确认THC形成。副产物的副作用的另一个假设可以是产品中的残留THC浓度作为污染,因为它们中的大多数基于含有除CBD之外的含有全光谱的粗麻血提取物。德国市场(大多数CBD油)的67种食品分析证实了这一假设:17种产品(25%)含有高于观察到的不良反应水平(2.5毫克/天)的THC。相反,CBD存在于低于未观察到的不利影响水平以下产品中。因此,可以假设一些商业CBD产物的不利影响基于THC的低剂量效应而不是由于CBD本身的影响。商业CBD产品的安全性,疗效和纯度非常高度可疑,我们样本收集中的所有产品显示出对欧洲食品法的各种不合格,如不安全的THC水平,全谱HEMP提取物作为未经批准的新型食品成分,未经批准的健康索赔,以及强制性食物标签要求的赤字。鉴于这种生活方式产品的日益增长的市场,食品业务运营商为产品安全责任的责任的有效性明显受到挑战。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号